| Pharmaceutical active ingredients: |
| Valproic Acid |
| Available forms, composition and doses of Depakine Zuur: |
| N / A |
| Depakine Zuur medical category: |
| Human:AnticonvulsantsAntimigraine preparationsAntipsychotics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N03AG01 - Valproic Acid |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Related documents and information about Depakine Zuur: |
| Depakene prescribing information (PDF)Depakene medication guide (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Depakine Chrono | Valproic Acid (Divalproex Sodium) | Sanofi-Aventis |
| Depakine Chrono Retard | Valproic Acid (Divalproex Sodium) | Sanofi-Aventis |
| Depakine Chronospere | Valproic Acid; Valproic Acid (Valproate Sodium) | Sanofi-Aventis |
| Depakine Chronosphere | Valproic Acid (Divalproex Sodium) | Sanofi-Aventis |
| Depakine Enteric | Valproic Acid (Valproate Sodium) | Sanofi-Aventis |
| Depalept | Valproic Acid (Valproate Sodium) | Sanofi-Aventis; C.T.S. Chemical Industries |
| Depalept Chrono | Valproic Acid; Valproic Acid (Valproate Sodium) | Sanofi-Aventis; C.T.S. Chemical Industries |
| Depamide | Valpromide | Sanofi-Aventis |
| Depot-H15-Insulin | Insulin Neutral Suspension Human highly purified crystalline | Sanofi-Aventis |
| Depot-H-Insulin | Insulin Neutral Suspension Human highly purified crystalline | Sanofi-Aventis |